Cannabidiol (CBD), derived from Cannabis sativa, has gained remarkable attention for its
potential therapeutic applications. This thorough analysis explores the increasing …

Neuropathic pain is a chronic debilitating condition caused by nerve injury or a variety of
diseases. At the core of neuropathic pain lies the aberrant neuronal excitability in the …

Background: Postoperative trigeminal neuropathy may be seen after surgery for middle and
posterior cranial fossa lesions. Although neuropathic pain is a cause of reduced quality of …

Botulinum neurotoxin type A BoNT/A is used off-label as a third line therapy for neuropathic
pain. However, the mechanism of action remains unclear. In recent years, the role of voltage …

Background: Chemotherapy-induced peripheral neurotoxicity (CIPN) affects the quality of
life of cancer survivors. However, the impact of pain on symptom burden remains undefined …

Background. Neuropathy affects 25% of people with diabetes mellitus. The evaluation of
disease severity is still a challenge for modern medicine. Many screening instruments are …

Introduction Neuropathic pain (NP) conditions involve lesions to the somatosensory nervous
system leading to chronic and debilitating pain. Many patients suffering from NP utilize …

Background. Migraine is a neurological disorder that results in disability accumulation, and
there are no blood‐based markers for indicating migraine susceptibility. Here, we aimed to …

Neuropathic pain is caused by a lesion or disease of the somatosensory system and is one
of the most incapacitating pain types, representing a significant non-met medical need. Due …

Chronic neuropathic pain (CNP) remains a significant clinical challenge, with complex
neurophysiological underpinnings that are not fully understood. Identifying specific neural …